Acupuncture and massage therapy for neuropathic pain following spinal cord injury: an exploratory study

Similar documents
The Use of Acupuncture to Decrease Chronic Neuralgia in Patients with Spinal Cord Injuries

ORIGINAL ARTICLE The International Spinal Cord Injury Pain Basic Data Set (version 2.0)

5.9. Rehabilitation to Improve Central Pain

Reliability and validity of the International Spinal Cord Injury Basic Pain Data Set items as self-report measures

Management of Pain related to Spinal Cord Lesion

Lars Jacobsson 1,2,3* and Jan Lexell 1,3,4

CANADIAN STROKE BEST PRACTICE RECOMMENDATIONS. Stroke Rehabilitation Evidence Tables Rehabilitation to Improve Central Pain

Effective Date: 01/01/2012 Revision Date: Code(s): Application of surface (transcutaneous) neurostimulator

Cecilia Norrbrink Budh, RPT, PhD 1,2, Jan Kowalski 3, Statistician and Thomas Lundeberg, MD, PhD 1,4

ACUPUNCTURE AND NEUROPATHIC PAIN

1 Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX, 2 Department of Anesthesiology, Baylor College

Spinal cord injury and quality of life: a systematic review of outcome measures

Daisy Cam. MS Specialist Nurse, Sheffield Teaching Hospitals NHS Foundation Trust

Peripheral Subcutaneous Field Stimulation

Spinal Cord Stimulation for chronic neuropathic and ischaemic pain

Peripheral Subcutaneous Field Stimulation. Description

Background (1) The CONECSI trial. Background (2) Intervention (2) Intervention (1)

Motohiro Inoue, 1 Miwa Nakajima, 1 Tatsuya Hojo, 2 Hiroshi Kitakoji, 1 Megumi Itoi 3. Original paper

Effectiveness of True Acupuncture as an Adjunct to Standard Care or Electro-Physiotherapy in Osteoarthritis of the Knee

Syllabus. Questions may appear on any of the topics below: I. Multidimensional Nature of Pain

7 th November % of patients had lidocaine plasters prescribed for the licensed indication of post herpatic neuralgia

Scottish Medicines Consortium

Follow this and additional works at: Part of the Medicine and Health Sciences Commons

National Horizon Scanning Centre. Pregabalin (Lyrica) for fibromyalgia. September 2007

Transcutaneous Electrical Nerve Stimulation for Low Back Pain

Acupuncture versus Sham Acupuncture for Chronic Prostatitis/Chronic Pelvic Pain

Getting at the CORE of Low-back pain Treatment Dr. John Flannery Dr. Carlo Ammendolia

Medizinische Klinik 1 und Klinische Chemie, University Hospital, Heidelberg, Germany *PMH and MM contributed equally.

Thilo Kroll, Ph.D. 1, 2 ; Matthew.E.Kehn, B.A. 2 ; Suzanne L. Groah, M.D. 2. National Rehabilitation Hospital, Washington, DC

Managing Diabetic Peripheral Neuropathic Pain

Is Topical Clonazepam More Effective Than Oral Clonazepam in Treatment of Burning Mouth Syndrome (BMS)?

Peripheral Subcutaneous Field Stimulation

Peripheral Subcutaneous Field Stimulation

6 Months Observational Study

Management of Neuropathic pain

INTERNATIONAL SPINAL CORD INJURY DATA SETS PAIN BASIC DATA SET

MEDICAL POLICY SUBJECT: KETAMINE INFUSION THERAPY FOR THE TREATMENT OF CHRONIC PAIN SYNDROMES POLICY NUMBER: CATEGORY: Technology Assessment

Neuropathic Pain and Pain Management Options. Mihnea Dumitrescu, MD

Spinal Cord Injury Pain. Michael Massey, DO CentraCare Health St Cloud, MN 11/07/2018

ORIGINAL ARTICLE A pilot feasibility study of massage to reduce pain in people with spinal cord injury during acute rehabilitation

POSITION STATEMENT PROPOSAL ON MASSAGE AND FIBROMYALGIA

Neuropathic Pain in Palliative Care

Neuropathic Pain Treatment Guidelines

16 year old with Disabling Chest Wall Pain after Thoracoscopic Talc Pleurodesis for Treatment of Recurrent Spontaneous Pneumothoraces

Peripheral neuropathy

Acupuncture Thaws Frozen Shoulder

REFRACTORY TRIGEMINAL NEURALGIA: IS BOTULINUM THE ANSWER? By: Amanda Fontes. Home for the Summer Program May to August Pine Falls, Manitoba

Original Article. Annals of Rehabilitation Medicine INTRODUCTION

Chen JC, Mannino DM. Worldwide epidemiology of chronic obstructive pulmonary disease. Curr Opin Pulm Med 1999; 5: 93 9.

INTERNATIONAL SPINAL CORD INJURY PAIN BASIC DATA SET Version 2.0

Medical Policy Manual. Topic: Peripheral Subcutaneous Field Stimulation Date of Origin: April Section: Surgery Last Reviewed Date: April 2014

The Efficacy of the Back School

Peripheral Subcutaneous Field Stimulation

Neuropathic pain (pain due to nerve damage)

Individual Study Table Referring to Part of Dossier: Volume: Page:

Various Types of Pain Defined

Placebo Response in Chronic Pain: What Have We Learned

Supplementary Online Content

COMPOUNDING PHARMACY SOLUTIONS PRESCRIPTION COMPOUNDING FOR PAIN MANAGEMENT

Summary of Selected Spinal Cord Stimulation Studies

CRITICALLY APPRAISED PAPER (CAP)

Infosheet. Peripheral neuropathy. What is peripheral neuropathy? The peripheral nervous system

Pain teaching. Muhammad Laklouk

Scrambler therapy in the management of somatosensory signs and symptoms related to neuropathic pain: an exploratory and prospective analysis

Case Information: DORSAL ROOT GANGLION SPINAL CORD STIMULATION & POST HERPETIC NEURALGIA (PHN)

An audit of acupuncture in general practice

Complex Regional Pain Syndrome: Manifestations and the Role of Neurostimulation in Its Management

3/7/2018. IASP updated definition of pain. Nociceptive Pain. Transduction. (Nociceptors) Transmission. (Peripheral nerve) Modulation

Percutaneous Neuromodulation Therapy: Does the Location of Electrical Stimulation Effect the Acute Analgesic Response?

Does needling sensation (de qi) affect treatment outcome in pain? Analysis of data from a larger single-blind, randomised controlled trial

Diagnosis of Neuropathic Pain. Didier Bouhassira

Original Policy Date

Diagnosis and Treatment of Postherpetic Neuralgia

Intramuscular stimulation therapy for healthcare: a systematic review of randomised controlled trials

Pain Management in the Elderly. Dr Cathy Price

01/07/2018 ISCHAEMIC PAIN IN NON-RECONSTRUCTABLE CRITICAL LIMB ISCHAEMIA PRESENTATION OUTLINE

Randomised Controlled Trial for Low Back Pain

FOCUS: Fluoxetine Or Control Under Supervision Results. Martin Dennis on behalf of the FOCUS collaborators

Peripheral neuropathy

Capsaicin cutaneous patch

Corporate Medical Policy

East-West Research. Samples of Journal Abstracts

The Role of Pregabalin in Fibromyalgia

Medical Policy. Description/Scope. Position Statement. Rationale

Clinical Commissioning Policy Statement: Sphenopalatine Ganglion Stimulation for Refractory Chronic Cluster Headache (Adults)

Refractory Central Neurogenic Pain in Spinal Cord Injury. Case Presentation

Effect of minimal acupuncture for infantile colic: a multicentre, three-armed, single-blind, randomised controlled trial (ACU-COL)

INTERNATIONAL SPINAL CORD INJURY PAIN EXTENDED DATA SET (Version 1.0)

GUIDELINES AND AUDIT IMPLEMENTATION NETWORK

Katsuyoshi Tanaka 1) Tomohiko Nishigami 2) Akihisa Watanabe 3) Akira Mibu 1) Hirobumi Kawamura 2) Masahiro Utsumi 3) Koji Hattori 2) ORIGINAL ARTICLES

Considering Your Non-opioid Options for Pain

PAIN MANAGEMENT & MAXIMIZING QUALITY OF LIFE DURING TREATMENT

NEUROPATHIC PAIN SECTION

9/2/2010. Welcome. Nationwide Children s Hospital. Follow the Journey of Children with Chronic Pain. ASPMN Conference September 25, 2010

Fibromyalgia , The Patient Education Institute, Inc. id Last reviewed: 03/12/2017 1

Prof Wayne Derman MBChB,BSc (Med)(Hons) PhD, FFIMS. Pain Management in the Elite Athlete: The 2017 IOC Consensus Statement

Dr. Ali D. Abbas.

SUMMARY OF MEDICAL TREATMENT GUIDELINE FOR CARPAL TUNNEL SYNDROME AS IT RELATES TO PHYSICAL THERAPY

Downloaded from zjrms.ir at 4: on Monday September 24th 2018 VAS.

Participation in everyday life and life satisfaction in the stroke-caregiver dyad

Transcription:

1 Department of Clinical Sciences, Karolinska Institutet, Danderyd Hospital, Stockholm, Sweden 2 Neuro-Spinal Division, Department of Physical Therapy, Karolinska University Hospital, Stockholm, Sweden 3 Foundation for Acupuncture and Alternative Biological Treatment Methods, Sabbatsbergs Hospital, Stockholm, Sweden Correspondence to Cecilia Norrbrink, Department of Clinical Sciences, Karolinska Institutet, Danderyd Hospital, Stockholm 18288, Sweden; cecilia.norrbrink@ki.se Accepted 11 February 2011 Published Online First 6 April 2011 108 Acupuncture and massage therapy for neuropathic pain following spinal cord injury: an exploratory study Cecilia Norrbrink, 1 2 Thomas Lundeberg 3 ABSTRACT Objective The study sought to explore the possibility of using acupuncture and massage therapy for relieving neuropathic pain following spinal cord injury (SCI). Design 30 individuals with SCI and neuropathic pain were assigned to treatment of either massage or acupuncture, with 15 individuals in each group. Both groups received treatment twice weekly for 6 weeks. Treatments were evaluated at the end of treatment and 2 months later (follow-up). Results Data were analysed on an intention- totreat basis. Within the groups, ratings of present pain, general pain, pain unpleasantness and coping improved signifi cantly at the end of treatment after acupuncture compared to baseline values, and following massage therapy ratings of pain interference on the Multidimensional Pain Inventory improved. At follow-up no signifi cant improvements were seen. Between-group differences were seen regarding ratings of worst pain intensity at the end of treatment, and regarding pain unpleasantness and coping with pain at follow-up, both in favour of acupuncture. At the end of treatment, eight of the 15 individuals receiving acupuncture and nine receiving massage reported an improvement on the Patient Global Impression of Change Scale, and at follow-up six patients in the acupuncture group and one patient in the massage group still reported a favourable effect from the treatment. Few side effects were reported and neither dropout from the study did this due to adverse events. Conclusion Neuropathic pain following SCI is often only partially responsive to most interventions. Results from this study indicate, however, that both acupuncture and massage therapy may relieve SCI neuropathic pain. For this reason, larger randomised controlled trials are warranted for assessing the long-term effects of these treatments. INTRODUCTION We lack knowledge of how to treat neuropathic pain due to spinal cord injury (SCI) satisfactorily. Treatment is therefore a great challenge for care givers. 1 Current treatment recommendations are based on the few studies of this patient group and on algorithms for treating peripheral neuropathic pain. With these tools we can sometimes relieve such pain following SCI to some extent, but rarely enough for the individuals to be satisfied. The lack of satisfaction can also be related to the fact that many of the drugs used have severe unwanted side effects. Regarding other treatments, sensory stimulation with transcutaneous electrical nerve stimulation has been studied mainly in peripheral neuropathic pain conditions and is considered to be an effective complement. 2 In some individuals with central neuropathic pain, transcutaneous electrical nerve stimulation may induce pain alleviation 3 but often less than in peripheral neuropathies. In rodent studies, acupuncture has been studied after peripheral nerve injury and is effective for hyperalgesia 4 and allodynia, 5 6 signs considered as consequences of nerve damage and associated with neuropathic pain. Treatment with acupuncture has, however, not been extensively studied in peripheral or central neuropathic pain conditions in humans. Only two randomised controlled studies have been carried out 7 8 and both report no or very little difference between acupuncture and the control treatment. However, in one of these studies verum acupuncture was compared to sham acupuncture, defined as needle insertions in deep muscles but not in acupuncture points followed by needling stimulation. This type of control is controversial since it is most likely not an inert treatment. 9 Two uncontrolled studies showed positive effects compared to baseline values when treating diabetic neuropathy 10 and HIV-related neuropathic pain. 11 In SCI, a within-subject-design study using acupuncture showed promising results for treating overall pain but less good for the cohort with central neuropathic pain. 12 Still, in 42% of those individuals, pain intensities were alleviated by at least two units on a 0 10 numerical rating scale (NRS) which is not a negligible effect in this patient group. Massage therapy has not been studied for treating neuropathic pain following SCI but it decreased anxiety 13 in individuals with SCI. In a previous survey 14 individuals with SCI reported massage to be one of the most effective non-pharmacological treatments for SCI chronic pain but spoke less of acupuncture. Similar results have been reported in other 15 16 studies. Acupunct Med 2011;29:108 115. doi:10.1136/aim.2010.003269

Based on these results an exploratory study was designed to assess the possibility of using medical acupuncture and massage therapy for relieving neuropathic pain due to SCI. Both treatment modalities activate endogenous pain inhibitory systems, however they are believed to act 17 18 through different mechanisms. METHODS AND INDIVIDUALS Individuals Individuals with SCI and pain were recruited from a spinal unit in Stockholm, Sweden through advertisements and through mailed enquiries. Inclusion criteria were an SCI more than 2 years previously and pain diagnosed as neuropathic at or below level 19 due to the SCI of more than 6 months duration. All individuals were asked not to change current pain medication or any other treatments during the treatment period but were allowed to stay on concurrent medication. Study design The study was carried out using a sequential controlled design. The first 15 individuals giving informed consent for the study and fulfilling the inclusion criteria were assigned to western medical acupuncture and the following 15 to massage. The assignation procedure was unknown to the individuals who were all willing to receive both acupuncture and massage. The treatment period consisted of 6 weeks with treatment twice weekly. The treatments were evaluated at the end of treatment and at follow-up 2 months later using a mailed questionnaire. Acupuncture Acupuncture points were chosen individually and needles were inserted in areas with preserved sensation. Points were chosen from a western medical perspective, that is, placed in areas with pain and in strong general acupuncture points. In addition, earpoint Shenmen and GV20 were selected as possible complements. Needle insertion was carried out using the recommended depth allowing for muscle stimulation. 20 Stimulation was initially manual and from the third or fourth session four points were stimulated with high frequency (80 Hz) electroacupuncture (CEFAR Acus 4; Cefar AB, Lund, Sweden). Points stimulated in the upper extremity were either LI11 LI4, LI15 LI11 or LI15 LI4, and in the lower extremity ST32 GB34, ST32 ST36 or BL54 BL54. In total 13 15 points were used in each session. The intensity was high, giving non-painful paresthesia. During manual acupuncture de qi was elicited three times at each session of 30 min. The acupuncture procedure is described according to the Standards for Reporting Interventions in Clinical Trials of Acupuncture. 21 Massage Classical massage therapy was carried out in areas with pain and preserved sensation with individuals lying on a massage table. The massage consisted of non-painful light pressure effleurage and petrissage. It was important that the massage did not cause discomfort for the individuals and therefore stimulation in areas with allodynia or unpleasant feelings from touch were avoided. Outcome measures Primary outcome measures The individuals rated their general and their worst pain intensities, and pain unpleasantness, during the last week using a visual analogue scale (VAS). They also rated present pain intensity at baseline, at the end of treatment (6 weeks) and at follow-up (2 months). In addition they rated the global pain-relieving effect on the Patient Global Impression of Change Scale (PGIC) 22 at both end of treatment and follow-up. A decrease of two units or more in pain intensity ratings on a 0 10 NRS 23 has been considered clinically significant, and 1.8 units or more in individuals with SCI (defined as my pain decreased to a meaningful extent ). 24 Translated to a VAS with a range of 0 100, a decrease of 18 units or more was considered to identify a responder. Secondary outcome measure As secondary outcome measures the Hospital Anxiety and Depression Scale was used to rate anxiety and depression, 25 the Multidimensional Pain Inventory Swedish language version (MPI-S) 26 part I, to assess the psychosocial consequences of pain, and a sleep questionnaire 27 to assess quality of sleep. Further, Fugl-Meyer s Life Satisfaction instrument (LiSat 9) 28 29 was used. In the analysis only the global rating of life satisfaction was considered. In addition, individuals rated how well they were able to cope with their pain on an 11-point NRS anchored not at all (0) and very good (10). Spasticity was assessed using the modified Penn Spasm Frequency Scale, 30 for frequency and severity. Spasm frequency is reported from 0=no spasms to 4=spontaneous spasms occurring >10/h, and severity of spasms from 1=mild to 3=severe. The study was approved by the Regional Ethics Approval Board in Stockholm, Sweden. Statistics Data were analysed on an intention-to-treat basis with missing data in dropouts replaced using the last-observation carried-forward method. Patient and treatment characteristics are presented using descriptive statistics: number of observations, mean and SD. Outcome variables are further presented by group using median and IQR before and after treatment. Determination of the between-treatment difference measured with the PGIC was tested with the Mann Whitney U test and the difference in number of respondents using the two-tailed Fisher exact test. Svensson s rank-invariant method 31 was used to estimate systematic changes in outcome variables (pain intensity, pain unpleasantness, coping, sleep quality, mood, life Acupunct Med 2011;29:108 115. doi:10.1136/aim.2010.003269 109

satisfaction, psychosocial consequences and spasticity) directly after treatment compared to baseline, and also 2 months after treatment compared to baseline. Systematic group changes are explained by relative change in position (RP), that is, the proportion of individuals with a higher level minus the proportion of those with a lower level in the outcome variable. RP values range from 1 (all individuals decreased) to +1 (all individuals increased). Values close to 0 indicate a negligible systematic group change in the outcome measure. When RP 0, the values after treatment are systematically higher (+) or lower ( ) for the group than the initial values. RP was estimated together with the corresponding 95% CI. SE was calculated using the jack knife method. Differences between acupuncture and massage was estimated as the difference between RPs together with the corresponding 95% CI. Negative differences between interventions (acupuncture vs massage) indicate that a larger proportion of individuals in the massage group decreased (or increased less) from baseline to the end of treatment, compared to those in the acupuncture group in the outcome variable. All the tests were two-sided, and a significance level of 0.05 was chosen. All descriptive statistics were produced in STATISTICA V.7.0 (StatSoft, Tulsa, Oklahoma, USA) and RP values were calculated in SYSRAN V.1.0 (JK Biostatistics, Stockholm, Sweden) for Matlab V.6.0 (The MathWorks, Natick, Massachusetts, USA). RESULTS Altogether 30 individuals were included in the study; 15 received acupuncture and 15 massage. The acupuncture group consisted of 12 males and 3 females with a mean age of 47.1 years (SD 11.1) and the massage group of 13 males and 3 females, mean age 49.8 (SD 9.2). Mean time since injury was 11.9 years (SD 12.3) in the acupuncture group and 12.9 years (SD 9.0) in the massage group. In the acupuncture group, 11 had a traumatic injury compared to 10 in the massage group. Five of those receiving acupuncture and six of those receiving massage had tetraplegia. Ten of those in the acupuncture group and eight of those in the massage group were on concomitant pain medication including adjuvant analgesics. Treatment The acupuncture group received a mean of 10.5 treatments (SD 2.9) and the massage group 11.1 treatments (SD 2.1). One acupuncture patient s treatment was concluded after only eight sessions due to complete pain relief. Lacking compliance, one individual received only three sessions of electroacupuncture and thereafter manual stimulation. Two individuals dropped out of the study, one in each treatment group, for reasons not related to the treatment itself. The acupuncture-group member moved abroad after one treatment and the massage-group member was hospitalised for pneumonia after eight treatments. One massage-group member did not return the follow-up questionnaire. Adverse events Compliance was high for both types of treatment. Almost half of those in the acupuncture group (n=7) reported being tired after the treatment initially and one reported a pain increase lasting 4 5 h after the treatment. Of those receiving massage, two reported soreness, one increased pain and one feeling extremely cold 4 5 h after the treatment resulting in poor sleep the first night after treatment. Positive events The acupuncture group reported the following positive side effects at the end of the treatment period: improved sleep (n=2), improved bladder (n=1) and bowel (n=1) function, decreased spasticity, less allodynia, more energy, less pain medication, feeling calm and relaxed (n=1 each). The massage group reported: improved function/less stiffness (n=6), improved sleep (n=5), improved relaxation Acupunct Med: first published as 10.1136/aim.2010.003269 on 6 April 2011. Downloaded from http://aim.bmj.com/ Present pain General pain Worst pain Pain unpleasantness Coping Anxiety Depression Global life satisfaction Sleep quality MPI - pain severity MPI - pain interference MPI - perceived life control MPI - social support MPI - affective distress In favour of acupuncture In favour of massage -1,0-0,8-0,6-0,4-0,2 0,0 0,2 0,4 0,6 0,8 1,0 Present pain General pain Worst pain Pain unpleasentness Median Min-Max Coping Anxiety Depression Sleep quality In favour of acupuncture In favour of massage -1,0-0,8-0,6-0,4-0,2 0,0 0,2 0,4 0,6 0,8 1,0 Median Min-Max on 14 June 2018 by guest. Protected by copyright. Figure 1 Between group differences at the end of treatment and at 2 months follow-up. 110 Acupunct Med 2011;29:108 115. doi:10.1136/aim.2010.003269

(n=2), less spasticity (n=3), improved circulation (warm legs; n=2), less allodynia (n=2), fewer painful attacks (n=2), less medication (n=1). At the follow-up individuals could report late-onset improvements. One patient reported improved sleep after acupuncture. In the massage group one reported using less muscle relaxants, and another increased wellbeing and mobility. Primary outcome measures pain and PGIC Between-group differences At the end of treatment (6 weeks), there was a significant difference between the two groups in ratings of worst pain intensity (figure 1). There was also a significant change at follow-up (2 months) regarding ratings of pain unpleasant- Figure 2 Ratings of global pain relieving effect on the Patient Global Impression of change Scale. ness; both in favour of acupuncture. No other differences between the two groups were detected. At the end of treatment, 8/15 individuals on acupuncture and 9/15 on massage reported an improvement on the PGIC (minimally improved very much improved, figure 2). At follow-up 6/15 on acupuncture and 1/15 on massage still reported a positive outcome. The difference between the two groups was not statistically significant. Numbers of responders calculated as all those reporting a decrease in pain ratings of 18 mm measured with VAS are shown in figure 3. The differences seen were not statistically significant. Ratings of general pain intensity and pain unpleasantness at end of treatment and follow-up are shown in figure 4 plotted against the baseline values. Figure 3 Number of patients reporting a decrease of 18 units or more on a visual analogue scale at the end of treatment and at the 2 months follow-up. There were no statistically signifi cant changes between those treated with massage and those treated with acupuncture calculated with Fisher s exact two-tailed test. Acupunct Med 2011;29:108 115. doi:10.1136/aim.2010.003269 111

Acupunct Med: first published as 10.1136/aim.2010.003269 on 6 April 2011. Downloaded from http://aim.bmj.com/ Figure 4 Ratings of pain intensity and pain unpleasantness plotted at end of treatment and follow-up Within-group differences Ratings of general and present pain, and of pain unpleasantness, all decreased significantly at end of treatment with acupuncture but not after massage. In terms of median decrease in pain intensity ratings measured with VAS, this was similar in the two groups (table 1). At follow-up no within-group differences were seen between pain variables. Secondary outcome measures At the end of treatment there were no between-group differences regarding the secondary outcome measures for pain or spasticity; but at follow-up, ratings of coping with pain as shown with a 0 10 NRS were in favour of acupuncture (figure 1). Within the groups, individuals on acu- puncture reported improvement in coping with pain, and those on massage reported less pain interference. At follow-up no improvements were seen, but massage-group members reported worsened coping. To see whether any of the assessed variables were important for ratings of coping with pain, a Spearman regression analysis was carried out. Pain intensity (r= 0.57), pain unpleasantness (r= 0.61), mood (r= 0.58), sleep (r= 0.55), MPI-pain severity (r= 0.67), MPI-pain interference (r= 0.59), MPI-perceived life control, (r=0.61) and MPI-affective distress (r= 0.65) all correlated moderately (r=0.50 to 0.69) 32 with ratings of coping. Ratings of global life satisfaction had low (r=0.26 0.49) correlation with coping (r=0.46), and MPI- social support little if any (r<0.25; r= 0.06). on 14 June 2018 by guest. Protected by copyright. 112 Acupunct Med 2011;29:108 115. doi:10.1136/aim.2010.003269

Table 1 Median values presented with IQR for primary and secondary outcome measures at baseline, end of treatment and follow-up Acupuncture DISCUSSION In this exploratory study the average pain alleviation following a treatment course of acupuncture or massage was small but significant. It was larger for the affective component of pain than for the sensory component (intensity). At follow-up no significant effects on pain intensity or unpleasantness were maintained, but six of 15 acupuncture-group members versus one of 15 on massage still reported an improvement on the PGIC. Between-group differences, in favour of acupuncture, were seen only regarding ratings of worst pain intensity. Both methods presented few unwanted side effects and compliance was high. None dropped out due to adverse events. The most pronounced effects were those of acupuncture on ratings of pain unpleasantness where a median decrease of 23/100 VAS units was seen immediately after the course. Acupuncture treatment reportedly modulates activity in limbic structures, 33 which could partly explain these findings. Effects of treatment on pain unpleasantness are not always assessed in clinical trials but they are recommended as an outcome measure. 22 Ratings of pain intensity also decreased significantly after treatment with acupuncture. The median decrease in ratings of present pain intensity was 19/100 VAS units following acupuncture (general pain 15 units) and eight units following massage (general pain 14 units). In a large study of SCI neuropathic pain concluding that pregabalin has a positive effect on this type of pain, 34 the mean reduction in pain scores on a 0 10 NRS was 1.92 before controlling for placebo. In a comparative study on gabapentin and amitryptiline 35 in SCI and Massage Variable Baseline End of treatment Follow-up Baseline End of treatment Follow-up Present pain 59 (44 74) 40 (17 71) 65 (24 71) 40 (26 67) 32 (17 52) 59 (40 66) General pain 63 (53 70) 48 (32 80) 62 (28 85) 62 (33 70) 48 (28 62) 62 (48 70) Worst pain 84 (75 92) 71 (52 95) 80 (52 97) 63 (59 85) 70 (53 80) 77 (58 83) Pain unpleasantness 70 (56 77) 47 (22 62) 58 (24 75) 61 (36 67) 50 (25 71) 63 (52 72) Coping 5 (3 7) 7 (5 8) 6.5 (3 7.5) 7 (5 8) 7 (5 8) 6 (5 7) Mood Anxiety 5 (1 13) 3 (0 10) 4 (0 14) 5 (3 9) 5 (3 9) 6 (4 9) Depression 5 (1 9) 5 (1 8) 6 (1 12) 4 (3 9) 4 (2 9) 4 (2 9) Sleep quality 3.0 (2.4 3.5) 2.8 (2.4 3.2) 2.9 (2.4 3.2) 2.9 (2.6 3.3) 2.7 (2.1 3.3) 2.9 (2.4 3.3) Global life satisfaction 4 (3 4) 4 (4 5) 4 (3 5) 4 (3 4) MPI Pain severity 4.0 (3.0 5.0) 4.0 (2.0 4.5) 3.5 (2.5 4.0) 3.0 (2.5 3.5) Pain interference 3.6 (2.5 5.1) 3.2 (2.6 4.5) 3.4 (2.4 4.3) 2.9 (1.7 4.0) Perceived life support 3.0 (2.5 4.8) 3.8 (2.8 4.8) 3.5 (2.8 4.5) 3.8 (3.3 4.5) Social support 3.5 (3.0 5.0) 3.5 (3.0 5.0) 3.0 (2.5 4.5) 3.0 (2.0 4.5) Affective distress 3.0 (0.3 4.3) 2.3 (0.0 3.3) 2.3 (1.0 3.3) 2.3 (1.3 3.3) Spasticity Penn frequency scale 1.5 (1 3.5) 1.5 (1 2.5) 2 (1 3.5) 2 (1 3) 1 (1 2) 1 (1 2) Penn severity scale 2 (1.5 2.5) 2 (1 2) 2 (1 2) 2 (1 2) 2 (1 2) 2 (1 2) MPI, Multidimensional Pain Inventory. neuropathic pain, a mean decrease of VAS 2.14 was seen after treatment with amitryptiline and of VAS 0.75 after gabapentin. Hanley et al 24 reported that in SCI a reduction of 1.8 units or more on a 0 10 NRS was a clinically significant alleviation of pain, which we translated to 18 units on a 0 100 point VAS, and those reporting these values are defined here as responders. Even though no significant differences were seen between the two groups, immediately after the treatment course more individuals on acupuncture reported this amount of pain alleviation. Forty per cent (six of 15) versus 13% (two of 15) were responders regarding ratings of present and general pain intensity, figures similar to those found by Nayak et al 12 in SCI and central neuropathic pain. Those authors found that 42% (five of 12 individuals) reported a decrease of at least two units on an NRS following 15 treatment sessions with acupuncture. Even though both studies used very small samples, these results are considered promising. None of the present respondents reported worsening of pain using the PGIC, but one patient on acupuncture reported being minimally worse at the 2-month follow-up. Whether this was associated with the treatment course is not clear. In the study by Nayak and colleagues, 12 four of the total sample of 22 individuals reported an increase in pain intensity at end of treatment and that this persisted at follow-up. The reported average increase was 1.08 on a 0 10 NRS. Nowadays it is recommended 22 36 that the PGIC be added when evaluating the results of a clinical trial, since this instrument covers more aspects than only pain reduction. Our evaluation showed that the effects of both treatments rated on the PGIC were similar, with nine of 15 individuals (60%) on massage and eight of 15 (53%) on acupuncture Acupunct Med 2011;29:108 115. doi:10.1136/aim.2010.003269 113

reporting a favorable effect. At follow-up, six of 15 (40%) on acupuncture still reported an improvement but only one of 15 (7%) on massage. In a study on pregabalin for SCI neuropathic pain, 34 57% of those on active drug reported an improvement, using the PGIC immediately after the treatment period. This result is similar to those of both acupuncture and massage seen in the present study. Both methods of sensory stimulation assessed in this study seemed to be able to decrease pain short-term in individuals with SCI and neuropathic pain. However, a difference between the two stimulation methods was seen: many individuals reported a small reduction following massage, but few reported a major alleviation following acupuncture. Three on acupuncture experienced a dramatic effect and long-term improvement. These long-term pain-alleviating effects have been attributed to activation of pain-inhibiting systems in cortical and subcortical pathways. While individuals with SCI and neuropathic pain may have symptoms in common, the origins and the mechanisms of their pain may vary. Different mechanisms can lead to different responses to therapy, and for this reason larger studies are warranted where possible effects can be studied in subgroups. Both treatment modalities were safe and compliance was high. No individuals dropped out due to adverse events and no severe adverse events were reported. This is rare in pharmacological trials in the same patient group where the dropout rates are reportedly high with commonly used drugs: 16% on gabapentin, 18% on amitryptiline, 35 30% on pregabalin, 34 48% on tramadol 37 and 50% on gabapentin. 38 The treatments assessed had effects mainly on the primary outcome variable pain. However, individuals also reported that their coping ability had improved after treatment with acupuncture. This might be associated with the decrease seen in pain ratings. Ratings of pain interference also decreased after massage. No other effects on mood, sleep quality, life satisfaction or spasticity were seen after either treatment modality. This explorative study investigated few enrolled individuals, and with no placebo control. In addition the individuals were not randomised to the interventions. The results are therefore difficult to generalise. However, within-group effects were significant following acupuncture treatment, and while few individuals responded very well, the effects seen in these individuals were long lasting, highlighting the need for larger randomised controlled studies. Also, the fact that both treatments were safe and had high compliance is important when considering their use in pain alleviation. Note, though, that knowledge about type and intensity stimulation, stimulation sites and number of treatments for optimal effect is lacking, so there might be more effective ways of treating neuropathic pain following SCI with acupuncture. The severity of the pain condition in this patient group indicates that the acupuncture course should maybe be longer than 12 sessions, with additional follow-up treatments. CONCLUSION Neuropathic pain following SCI is a condition unresponsive to many interventions. Results from this study indicate that both acupuncture and massage therapy may relieve SCI neuropathic pain and for this reason larger randomised controlled trials are warranted for assessing the long-term effects of these treatments. Acknowledgement This study was made possible by grants from The Swedish Association of Persons with Neurological Disabilities. Excellent support from Jan Kowalski, statistician, is gratefully acknowledged. Competing interests None declared. Ethics approval This study was conducted with the approval of the Regional Ethics Approval Board in Stockholm, Sweden. Provenance and peer review Not commissioned; externally peer reviewed. REFERENCES 1. Siddall PJ. Management of neuropathic pain following spinal cord injury: now and in the future. Spinal Cord 2009;47:352 9. 2. Cruccu G, Aziz TZ, Garcia-Larrea L, et al. EFNS guidelines on neurostimulation therapy for neuropathic pain. Eur J Neurol 2007;14:952 70. 3. Norrbrink C. Transcutaneous Electrical Nerve Stimulation for treatment of spinal cord injury neuropathic pain. J Rehabil Res Dev 2009;46:85 93. 4. Dai Y, Kondo E, Fukuoka T, et al. The effect of electroacupuncture on pain behaviors and noxious stimulus-evoked Fos expression in a rat model of neuropathic pain. J Pain 2001;2:151 9. 5. Hwang BG, Min BI, Kim JH, et al. Effects of electroacupuncture on the mechanical allodynia in the rat model of neuropathic pain. Neurosci Lett 2002;320:49 52. 6. Cha MH, Choi JS, Bai SJ, et al. Antiallodynic effects of acupuncture in neuropathic rats. Yonsei Med J 2006;47:359 66. 7. Lewith GT, Field J, Machin D. Acupuncture compared with placebo in post-herpetic pain. Pain 1983;17:361 8. 8. Shlay JC, Chaloner K, Max MB, et al. Acupuncture and amitriptyline for pain due to HIV-related peripheral neuropathy: a randomized controlled trial. Terry Beirn Community Programs for Clinical Research on AIDS. JAMA 1998;280:1590 5. 9. White A, Cummings M, Barlas P, et al. Defi ning an adequate dose of acupuncture using a neurophysiological approach a narrative review of the literature. Acupunct Med 2008;26:111 20. 10. Abuaisha BB, Costanzi JB, Boulton AJ. Acupuncture for the treatment of chronic painful peripheral diabetic neuropathy: a long-term study. Diabetes Res Clin Pract 1998;39:115 21. 11. Phillips KD, Skelton WD, Hand GA. Effect of acupuncture administered in a group setting on pain and subjective peripheral neuropathy in persons with human immunodefi ciency virus disease. J Altern Complement Med 2004;10:449 55. 12. Nayak S, Shifl ett SC, Schoenberger NE, et al. Is acupuncture effective in treating chronic pain after spinal cord injury? Arch Phys Med Rehabil 2001;82:1578 86. 13. Diego MA, Field T, Hernandez-Reif M, et al. Spinal cord patients benefi t from massage therapy. Int J Neurosci 2002;112:133 42. 14. Norrbrink Budh C, Lundeberg T. Non-pharmacological pain-relieving therapies in individuals with spinal cord injury; a patient perspective. Complement Ther Med 2004;12:189 97. 15. Nayak S, Matheis RJ, Agostinelli S, et al. The use of complementary and alternative therapies for chronic pain following spinal cord injury: a pilot survey. J Spinal Cord Med 2001;24:54 62. 16. Warms CA, Turner JA, Marshall HM, et al. Treatments for chronic pain associated with spinal cord injuries: many are tried, few are helpful. Clin J Pain 2002;18:154 63. 17. Hui KK, Marina O, Claunch JD, et al. Acupuncture mobilizes the brain s default mode and its anti-correlated network in healthy subjects. Brain Res 2009;1287:84 103. 18. Sluka AK, Milosavljevic S. Manual therapy. In: Sluka KA, ed. Mechanisms and Management of Pain for the Physical Therapist. Seattle, US: IASP Press 2010:205 214. 19. Siddall PJ, Yezierski RP, Loeser JD. Pain following spinal cord injury: clinical features, prevalence, and taxonomy. IASP newsletter 2000-3. http://www.iasp-pain.org/am/ Template.cfm?Section=Home&Template=/CM/ContentDisplay.cfm&ContentID=2179 (accessed 29 Mar 2011). 20. Andersson S, Lund I, Lundeberg T, et al. Akupunktur Punkthandbok (Swedish). Kungälv: Grafi kerna Livréna 2002. 21. MacPherson H, Altman DG, Hammerschlag R, et al. Revised STandards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA): extending the CONSORT statement. Acupunct Med 2010;28:83 93. 22. Dworkin RH, Turk DC, Farrar JT, et al. Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain 2005;113:9 19. 114 Acupunct Med 2011;29:108 115. doi:10.1136/aim.2010.003269

23. Farrar JT, Young JP Jr, LaMoreaux L, et al. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain 2001;94:149 58. 24. Hanley MA, Jensen MP, Ehde DM, et al. Clinically signifi cant change in pain intensity ratings in persons with spinal cord injury or amputation. Clin J Pain 2006;22:25 31. 25. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361 70. 26. Bergström G, Jensen IB, Bodin L, et al. Reliability and factor structure of the Multidimensional Pain Inventory Swedish Language Version (MPI-S). Pain 1998;75:101 10. 27. Åkerstedt T, Torsvall L. Medical, Psychological, and Social Aspects of Shift Work at the Specialised Steel-Making Plants in Söderfors. National Institute for Psychosocial Medicine. Reports on Stress Research, No 64, 1977. 28. Fugl-Meyer A, Bränholm I, Fugl-Meyer K. Happiness and domain-specifi c life satisfaction in adult northern Swedes. Clin Rehabil 1991;5:25 33. 29. Fugl-Meyer AR, Melin R, Fugl-Meyer KS. Life satisfaction in 18 to 64-year-old Swedes: in relation to gender, age, partner and immigrant status. J Rehabil Med 2002;34:239 46. 30. Priebe MM, Sherwood AM, Thornby JI, et al. Clinical assessment of spasticity in spinal cord injury: a multidimensional problem. Arch Phys Med Rehabil 1996;77:713 16. 31. Svensson E. Guidelines to statistical evaluation of data from rating scales and questionnaires. J Rehabil Med 2001;33:47 8. 32. Munro BH. Correlations. In: Munro BH, Visintainer MA, Page EB, eds. Statistical Methods for Health Care Research. Philadelphia, PA: JB Lippincott Co 1993:181. 33. Hui KK, Marina O, Liu J, et al. Acupuncture, the limbic system, and the anticorrelated networks of the brain. Auton Neurosci 2010;157:81 90. 34. Siddall PJ, Cousins MJ, Otte A, et al. Pregabalin in central neuropathic pain associated with spinal cord injury: a placebo-controlled trial. Neurology 2006;67:1792 800. 35. Rintala DH, Holmes SA, Courtade D, et al. Comparison of the effectiveness of amitriptyline and gabapentin on chronic neuropathic pain in persons with spinal cord injury. Arch Phys Med Rehabil 2007;88:1547 60. 36. Bryce TN, Norrbrink Budh C, Cardenas DD, et al. Outcome measures for pain after spinal cord injury: and evaluation of reliability and validity. J Spinal Cord Med 2007;30:422 40. 37. Norrbrink C, Lundeberg T. Tramadol in neuropathic pain after spinal cord injury: a randomized, double-blind, placebo-controlled trial. Clin J Pain 2009;25:177 84. 38. Tai Q, Kirshblum S, Chen B, et al. Gabapentin in the treatment of neuropathic pain after spinal cord injury: a prospective, randomized, double-blind, crossover trial. J Spinal Cord Med 2002;25:100 5. Acupunct Med: first published as 10.1136/aim.2010.003269 on 6 April 2011. Downloaded from http://aim.bmj.com/ on 14 June 2018 by guest. Protected by copyright. Acupunct Med 2011;29:108 115. doi:10.1136/aim.2010.003269 115